方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| EORTC QLQ-C30：癌症生活质量评估的核心问卷× | 帕金森病问卷-39× | |
|---|---|---|
| 领域 | 健康结局 | 健康结局 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1993 | 1997 |
| 提出者≠ | Nico Aaronson et al. | Crispin Jenkinson et al. |
| 类型 | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| 开创性文献≠ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ | Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26(5), 353-357. DOI ↗ |
| 别名 | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale | PDQ-39, Parkinson's Disease Questionnaire, PDQ |
| 相关≠ | 5 | 4 |
| 摘要≠ | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. | The PDQ-39 is the most widely used patient-reported outcome measure for Parkinson's disease quality of life. Developed by Crispin Jenkinson and colleagues in 1997, this 39-item self-report questionnaire comprehensively assesses how Parkinson's symptoms affect daily functioning, emotional well-being, stigma, social support, and cognitive-communication abilities. It is the recommended instrument in major Parkinson's disease clinical trials and forms a core component of outcome measurement in movement disorders. |
| ScholarGate数据集 ↗ |
|
|